- Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
- Carisma Therapeutics to Present at Upcoming Conferences
- Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Carisma Therapeutics Announces Changes to its Board of Directors
- Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
- Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
More ▼
Key statistics
On Tuesday, Carisma Therapeutics Inc (CARM:NMQ) closed at 1.69, 10.46% above the 52 week low of 1.53 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.85 |
---|---|
High | 1.91 |
Low | 1.68 |
Bid | 1.69 |
Offer | 1.70 |
Previous close | 1.87 |
Average volume | 193.46k |
---|---|
Shares outstanding | 41.54m |
Free float | 27.95m |
P/E (TTM) | -- |
Market cap | 77.68m USD |
EPS (TTM) | -3.70 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 20:53 BST.
More ▼